Vasogenics (Services) Limited - Period Ending 2017-08-31

Registration number: 05321039

Vasogenics (Services) Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 August 2017

Vasogenics (Services) Limited

Contents

Balance Sheet	1
Notes to the Financial Statements	2 to 3

Vasogenics (Services) Limited

(Registration number: 05321039)
Balance Sheet as at 31 August 2017

	Note	2017 £	2016 £
Current assets
Debtors	3	35,622	35,622
Capital and reserves
Called up share capital		2,000	2,000
Profit and loss account		33,622	33,622
Total equity		35,622	35,622

For the financial year ending 31 August 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 5 January 2018
 

.........................................

Mr R H Doyle

Company secretary and director

The notes on pages 2 to 3 form an integral part of these financial statements.

Page 1

Vasogenics (Services) Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

1	General information

The company is a private company limited by share capital incorporated in England.

The address of its registered office is:
Auker Rhodes
Aire Valley Business Centre
Lawkholme Lane
Keighley
BD21 3BB
England

These financial statements were authorised for issue by the director on 5 January 2018.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

	2017 £	2016 £
Trade debtors	17,780	17,780
Other debtors	17,842	17,842
Total current trade and other debtors	35,622	35,622

Page 2

Vasogenics (Services) Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

4	Share capital

Allotted, called up and fully paid shares

	2017		2016
	No.	£	No.	£
A Ordinary shares of £1 each	2,000	2,000	2,000	2,000

Page 3